Enhancement of Corticosteroid Efficacy in COPD

NCT02340520 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: Theophylline
DRUG: Roflumilast

Sponsor

UConn Health